These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 23730418)

  • 1. Expression of DBC1 and Androgen Receptor Predict Poor Prognosis in Diffuse Large B Cell Lymphoma.
    Park HS; Bae JS; Noh SJ; Kim KM; Lee H; Moon WS; Chung MJ; Kang MJ; Lee DG; Jang KY
    Transl Oncol; 2013 Jun; 6(3):370-81. PubMed ID: 23730418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetylation status of P53 and the expression of DBC1, SIRT1, and androgen receptor are associated with survival in clear cell renal cell carcinoma patients.
    Noh SJ; Kang MJ; Kim KM; Bae JS; Park HS; Moon WS; Chung MJ; Lee H; Lee DG; Jang KY
    Pathology; 2013 Oct; 45(6):574-80. PubMed ID: 24018803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression of DBC1/CCAR2 is associated with poor prognosis of ovarian carcinoma.
    Cho D; Park H; Park SH; Kim K; Chung M; Moon W; Kang M; Jang K
    J Ovarian Res; 2015 Feb; 8():2. PubMed ID: 25823848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DBC1/CCAR2 is involved in the stabilization of androgen receptor and the progression of osteosarcoma.
    Wagle S; Park SH; Kim KM; Moon YJ; Bae JS; Kwon KS; Park HS; Lee H; Moon WS; Kim JR; Jang KY
    Sci Rep; 2015 Aug; 5():13144. PubMed ID: 26249023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics and outcomes of patients with diffuse large B cell lymphoma treated with R-CHOP-like or CHOP-like regimens: an 8-year experience from a single center.
    Huang H; Fan L; Fu D; Lin Q; Shen J
    Ann Palliat Med; 2020 Jul; 9(4):1442-1452. PubMed ID: 32648457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal and polyclonal gammopathy measured by serum free light chain and immunofixation subdivide the clinical outcomes of diffuse large B-cell lymphoma according to molecular classification.
    Kim YR; Kim SJ; Cheong JW; Kim Y; Jang JE; Lee JY; Min YH; Song JW; Yang WI; Kim JS
    Ann Hematol; 2014 Nov; 93(11):1867-77. PubMed ID: 24947797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of DBC1 is associated with poor prognosis in hepatitis virus-related hepatocellular carcinoma.
    Ha SY; Kim JH; Yang JW; Bae H; Cho HY; Park CK
    Pathol Res Pract; 2016 Jul; 212(7):616-21. PubMed ID: 27083241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SIRT1 expression is associated with poor prognosis of diffuse large B-cell lymphoma.
    Jang KY; Hwang SH; Kwon KS; Kim KR; Choi HN; Lee NR; Kwak JY; Park BH; Park HS; Chung MJ; Kang MJ; Lee DG; Kim HS; Shim H; Moon WS
    Am J Surg Pathol; 2008 Oct; 32(10):1523-31. PubMed ID: 18724249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High Ki-67 expression in diffuse large B-cell lymphoma patients with non-germinal center subtype indicates limited survival benefit from R-CHOP therapy.
    Li ZM; Huang JJ; Xia Y; Zhu YJ; Zhao W; Wei WX; Jiang WQ; Lin TY; Huang HQ; Guan ZZ
    Eur J Haematol; 2012 Jun; 88(6):510-7. PubMed ID: 22413767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of DBC1 and SIRT1 is associated with poor prognosis of gastric carcinoma.
    Cha EJ; Noh SJ; Kwon KS; Kim CY; Park BH; Park HS; Lee H; Chung MJ; Kang MJ; Lee DG; Moon WS; Jang KY
    Clin Cancer Res; 2009 Jul; 15(13):4453-9. PubMed ID: 19509139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Significance of
    Ting CY; Chang KM; Kuan JW; Sathar J; Chew LP; Wong OJ; Yusuf Y; Wong L; Samsudin AT; Pana MNBM; Lee SK; Gopal NSR; Puri R; Ong TC; Bahari SK; Goh AS; Teoh CS
    Int J Med Sci; 2019; 16(4):556-566. PubMed ID: 31171907
    [No Abstract]   [Full Text] [Related]  

  • 12. Expression of DBC1 and SIRT1 is associated with poor prognosis for breast carcinoma.
    Lee H; Kim KR; Noh SJ; Park HS; Kwon KS; Park BH; Jung SH; Youn HJ; Lee BK; Chung MJ; Koh DH; Moon WS; Jang KY
    Hum Pathol; 2011 Feb; 42(2):204-13. PubMed ID: 21056897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A retrospective analysis of clinical characteristics and prognostic factors for 124 cases of primary gastric lymphomas].
    He Y; Wang L; Zhu HY; Liang JH; Wu W; Wu JZ; Xia Y; Cao L; Fan L; Li JY; Xu W
    Zhonghua Xue Ye Xue Za Zhi; 2017 Jun; 38(6):505-510. PubMed ID: 28655094
    [No Abstract]   [Full Text] [Related]  

  • 14. Prognostic impact of germinal center B-cell-like and non-germinal center B-cell-like subtypes of bone marrow involvement in patients with diffuse large B-cell lymphoma treated with R-CHOP.
    Cho MC; Chung Y; Jang S; Park CJ; Chi HS; Huh J; Suh C; Shim H
    Medicine (Baltimore); 2018 Nov; 97(45):e13046. PubMed ID: 30407302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRPM4 expression is associated with activated B cell subtype and poor survival in diffuse large B cell lymphoma.
    Loo SK; Ch'ng ES; Md Salleh MS; Banham AH; Pedersen LM; Møller MB; Green TM; Wong KK
    Histopathology; 2017 Jul; 71(1):98-111. PubMed ID: 28248435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deleted in breast cancer 1 as a potential prognostic biomarker in human cancers: a pooled analysis of 2,254 patients.
    Liu G; Wu Q; Wang Y; Xiong Q; Fu F
    Onco Targets Ther; 2019; 12():1563-1574. PubMed ID: 30863120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of CD68, cyclin D1 and rearrangement of bcl-6 gene are adverse prognostic factors in diffuse large B-cell lymphoma].
    Liang X; Wang J; Bai W; Sun R
    Zhonghua Bing Li Xue Za Zhi; 2015 Aug; 44(8):559-64. PubMed ID: 26705179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MYC rearrangement and MYC/BCL2 double expression but not cell-of-origin predict prognosis in R-CHOP treated diffuse large B-cell lymphoma.
    Xu J; Liu JL; Medeiros LJ; Huang W; Khoury JD; McDonnell TJ; Tang G; Schlette E; Yin CC; Bueso-Ramos CE; Lin P; Li S
    Eur J Haematol; 2020 Apr; 104(4):336-343. PubMed ID: 31944390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BCL2 predicts survival in germinal center B-cell-like diffuse large B-cell lymphoma treated with CHOP-like therapy and rituximab.
    Iqbal J; Meyer PN; Smith LM; Johnson NA; Vose JM; Greiner TC; Connors JM; Staudt LM; Rimsza L; Jaffe E; Rosenwald A; Ott G; Delabie J; Campo E; Braziel RM; Cook JR; Tubbs RR; Gascoyne RD; Armitage JO; Weisenburger DD; Chan WC
    Clin Cancer Res; 2011 Dec; 17(24):7785-95. PubMed ID: 21933893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The different roles of molecular classification according to upfront autologous stem cell transplantation in advanced-stage diffuse large B cell lymphoma patients with elevated serum lactate dehydrogenase.
    Kim YR; Kim SJ; Cheong JW; Yang DH; Lee H; Eom HS; Sung YO; Kim HJ; Kang HJ; Lee WS; Park Y; Yang WI; Min YH; Kim JS
    Ann Hematol; 2016 Sep; 95(9):1491-501. PubMed ID: 27324387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.